Literature DB >> 16327283

Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival.

M Rodallec1, V Vilgrain, A Couvelard, P Rufat, D O'Toole, V Barrau, A Sauvanet, P Ruszniewski, Y Menu.   

Abstract

PURPOSE: To assess the role of contrast-enhanced helical CT in the evaluation of tumour vascularity in endocrine pancreatic tumours (EPTs), and to determine the predictive factors of malignancy of EPTs at helical CT with CT-histopathological correlation.
MATERIALS AND METHODS: Thirty-seven consecutive patients with histopathologically proven EPTs underwent dual-phase helical CT. For each tumour detected, its density relative to the surrounding parenchyma was scored on the pancreatic phase using a 5-point scale. Radiological findings were correlated with histopathological (vessel density count) and clinical follow-up findings.
RESULTS: Thirty of 37 patients had non-functioning EPTs and overall 44 tumours were detected by helical CT (mean size 38, range 5-100 mm). CT showed calcifications in 10 tumours. Calcifications were associated with well-differentiated carcinomas (90%, p = 0.02). Vascular density assessed by light microscopy was significantly correlated with tumour enhancement at the pancreatic phase (p = 0.0001). Poorly differentiated carcinomas were less vascularised than well-differentiated tumours and carcinomas (34 vs. 264 vessels/mm2, p = 0.0073). Tumour differentiation also correlated with tumour enhancement at the pancreatic phase (p = 0.0044, trend test): poorly differentiated carcinomas were hypoattenuating (71%) and isoattenuating or weakly hyperattenuating (29%), compared with well-differentiated carcinomas and tumours that were mainly moderately or strongly hyperattenuating (53%). In univariate analysis, poor tumoral differentiation, hepatic metastasis, high mitotic index, poor tumoral enhancement at the pancreatic phase and less vascularised tumours were correlated with decreased survival rate.
CONCLUSION: Enhancement of EPT at CT is correlated with tumour vascularity assessed by light microscopy. Low-enhancing EPT at CT are correlated with poorly differentiated EPT and with a decrease in overall survival. 2006 S. Karger AG, Basel and IAP

Entities:  

Mesh:

Year:  2005        PMID: 16327283     DOI: 10.1159/000090026

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  39 in total

Review 1.  Sunitinib in pancreatic neuroendocrine tumors.

Authors:  Eric Raymond; Pascal Hammel; Chantal Dreyer; Christian Maatescu; Olivia Hentic; Philippe Ruszniewski; Sandrine Faivre
Journal:  Target Oncol       Date:  2012-06-02       Impact factor: 4.493

2.  Pancreatic neuroendocrine tumours: hypoenhancement on arterial phase computed tomography predicts biological aggressiveness.

Authors:  David J Worhunsky; Geoffrey W Krampitz; Peter D Poullos; Brendan C Visser; Pamela L Kunz; George A Fisher; Jeffrey A Norton; George A Poultsides
Journal:  HPB (Oxford)       Date:  2013-08-29       Impact factor: 3.647

3.  Is the combination of MR and CT findings useful in determining the tumor grade of pancreatic neuroendocrine tumors?

Authors:  Fumihito Toshima; Dai Inoue; Takahiro Komori; Kotaro Yoshida; Norihide Yoneda; Tetsuya Minami; Osamu Matsui; Hiroko Ikeda; Toshifumi Gabata
Journal:  Jpn J Radiol       Date:  2017-03-03       Impact factor: 2.374

4.  Pancreatic neuroendocrine neoplasms: Correlation between MR features and pathological tumor grades.

Authors:  Feng Jin; Kai Wang; Ting-Ting Qin; Xin Li; Feng Guo; Gui-Na Ma; Xue-Han Hu; Ping Han
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

5.  A simple morphological classification to estimate the malignant potential of pancreatic neuroendocrine tumors.

Authors:  Atsushi Oba; Atsushi Kudo; Keiichi Akahoshi; Mitsuhiro Kishino; Takumi Akashi; Eriko Katsuta; Yasuhito Iwao; Hiroaki Ono; Yusuke Mitsunori; Daisuke Ban; Shinji Tanaka; Yoshinobu Eishi; Ukihide Tateishi; Minoru Tanabe
Journal:  J Gastroenterol       Date:  2017-05-09       Impact factor: 7.527

6.  Perfusion characterization of liver metastases from endocrine tumors: Computed tomography perfusion.

Authors:  Aurélie Guyennon; Marius Mihaila; John Palma; Catherine Lombard-Bohas; Jean-Alain Chayvialle; Frank Pilleul
Journal:  World J Radiol       Date:  2010-11-28

7.  Pancreatic neuroendocrine tumours: correlation between MSCT features and pathological classification.

Authors:  Yanji Luo; Zhi Dong; Jie Chen; Tao Chan; Yuan Lin; Minhu Chen; Zi-Ping Li; Shi-Ting Feng
Journal:  Eur Radiol       Date:  2014-07-22       Impact factor: 5.315

Review 8.  Prognostication and response assessment in liver and pancreatic tumors: The new imaging.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Gino Puntel; Silvia Ortolani; Sara Cingarlini; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

9.  Prognostic value of CT findings to predict survival outcomes in patients with pancreatic neuroendocrine neoplasms: a single institutional study of 161 patients.

Authors:  Dong Wook Kim; Hyoung Jung Kim; Kyung Won Kim; Jae Ho Byun; So Yeon Kim; Ki Byung Song; Nikhil H Ramaiya; Sree Harsha Tirumani; Seung-Mo Hong
Journal:  Eur Radiol       Date:  2015-08-08       Impact factor: 5.315

10.  Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma.

Authors:  Jung Hoon Kim; Hyo Won Eun; Young Jae Kim; Jeong Min Lee; Joon Koo Han; Byung-Ihn Choi
Journal:  Eur Radiol       Date:  2015-08-08       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.